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Background: HIV-positive women have an increased risk of developing cervical cancer (CC) compared to the
HIV-negative women. Despite this, HIV and CC screening programs in many developing countries have remained
disintegrated. Therefore, the objective of the study was to explore perceptions of healthcare providers (HCP) and
policy makers (PM) about integration of HIV and CC screening services in Uganda.
Methods: This was a qualitative study conducted among 16 participants comprising of 12 healthcare providers
and 4 policy makers in Uganda. Data were collected through individual interviews. Participants were purposively
selected from different level of health facilities with clinics for HIV and CC screening services. Content analysis
method was used to analyze the data.
Results: Three themes emerged from the data, namely appreciating benefits of integration, worrying about the
limited health system capacity and potential consequences of integration and feeling optimistic about integration
under improved health system conditions. The benefits embraced the women – particularly the HIV-positive
women- but also men, healthcare providers and the health system or the government. There were worries that
HIV stigma and shortage of healthcare workers would affect the effective delivery of the integrated program.
Conclusion: Integration of HIV and CC screening can offer manifold benefits to all stakeholders in the health
system, more so to the women. However, its feasibility in developing countries such as Uganda will most likely be
hampered by weak and inefficient health systems. Therefore, when considering HIV and CC screening integration,
it is important not to only recognize the benefits but also take into account resources requirements for addressing
the existing weaknesses and inefficiencies in the health systems such as limited infrastructure, insufficient drugs and
supplies, inadequate and poorly motivated healthcare workers.
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Cervical cancer (CC) is the second most common cancer
among women globally, with an estimated 529,409 new
cases and 274,883 deaths in 2008 [1]. About 86% of the
deaths occur in developing countries, making it the
leading cause of cancer death among women [2]. In
Uganda, CC is the commonest cancer among women.
The age-standardized incidence rate for CC is on the
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article, unless otherwise stated.early 1960s to 47.5/100,000 women person years in
2008 which is one of the highest in the world [3,1].
HIV-positive women have an increased risk of devel-
oping CC compared to the HIV-negative women [4-8].
In view of the above, the World Health Organization
(WHO) recommends more aggressive re-screening sched-
ule for HIV-positive women compared to HIV-negative
women [9]. More so, HIV and human papillomavirus
(HPV), the cause of CC [10,11] are both sexually transmit-
ted infections (STIs) and so share the same risk factors
such as multiple sexual partners [12-14].
In view of this, interventions for HIV and CC prevention
such as screening should ideally be delivered in antral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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that there is a large potential health gain if HIV and
CC prevention services are integrated [15,16]. Policy
makers (PM)s from disciplines outside the cancer
domain—for example HIV care — are warranted to
create CC prevention services for women attending
that programs/facilities [16].
Recent studies have also demonstrated various models
of integrating HIV and CC screening services including
information on their effectiveness and acceptability
among the HIV-positive women. For example, in Zambia
where CC prevention clinics were co-located within
the public health clinics offering HIV/AIDS care and
treatment, manifold advantages were observed including
resource and infrastructure sharing, availability of a wider
range of women’s health services for HIV-infected/at-
risk women, and opportunities for referral between the
clinic systems and maximization of participation in both
programs [17]. The above study also pointed out that
stigma associated with HIV/AIDS somehow affected the
uptake of the integrated services. Similarly, in Kenya were
CC screening services were integrated into mother, child
health (MCH) and family planning (FP) clinics, it was
reported that a high proportion of women who visited
the MCH-FP clinics for well-baby or family planning
services also benefited from CC and sexually transmitted
infections (STIs) screening and treatment services in a
single visit approach [18]. In Nigeria, where women
seeking reproductive health (RH) or HIV care services
were bi-directionally referred to either HIV care or RH
clinics co-situated within the same health facility, it was
demonstrated that CC screening by visual inspection with
5% acetic acid (VIA) was highly acceptable and facilitated
early detection and treatment of very many cases of cervical
pre-cancerous lesions among women [19,20].
Despite the above evidence and recommendations, in
Uganda and many other developing countries, HIV and
CC screening services continue to be implemented as
standalone programs. As disintegrated clinics, almost all
the HIV care programs in Uganda do not offer CC
screening services and hence the female HIV patients
miss CC screening opportunities despite the frequent
visits they make to the HIV facilities for reviews and
drug refills. This increases their risk of presenting late
with advanced CC disease with poor prognosis. Simi-
larly, almost all CC screening programs in Uganda do
not offer HIV screening services to women and hence
the women risk receiving inappropriate schedules for
CC re-screening. Less aggressive CC re-screening interval
for HIV positive women similarly increases the risk of
them presenting late with advanced CC disease with
poor prognosis.
Therefore, the objective of this study was to explore




This was a qualitative study. It was chosen to allow for
in-depth exploration of perceptions of the integrated
approach to delivery of HIV and CC screening services,
the phenomenon under investigation [21,22].
Study sites
The study was conducted at CC clinics in 4 districts
in Uganda namely Kampala, Mbarara, Ibanda and
Nakasongola but the participants were drawn from 9
clinics of 7 health facilities and 4 district health
offices within the 4 districts. Table 1 shows the clinic
characteristics. These districts and clinics provided
perspectives of urban, semi-urban, rural and remote
settings of Uganda. More so, these study sites provided
the perspectives of the different levels of healthcare in
Uganda in addition to public and private health sectors
perspectives.
At the time of the study, all the study clinics have
implemented CC screening services for at least 3 years.
And the CC screening services they provided included
health education talks, counseling, CC screening by VIA,
treatment of cervical precancerous lesions using cryother-
apy, referral for CC diagnosis, staging and treatment and
reviews of women after cryotherapy. More so, all the study
clinics were not implementing an integrated delivery of
HIV and CC screening services with an exception of
only one private facility situated in an urban setting.
And therefore, the HIV status of the women were
established through history and those who have never
tested for HIV were presumed and in most of the time
treated as HIV negative women.
Selection criteria for study sites
Seven health facilities were purposively selected to partici-
pate in the study. A health facility is eligible for selection
to participate in the study if it is situated in any of the
four study sites namely Kampala, Mbarara, Ibanda and
Nakasongola districts and has clinics that provide HIV
and CC screening services.
Study participants and sample size
Sixteen participants were selected for the study. They
were 12 healthcare providers and 4 district level policy
makers. The healthcare providers included medical doctors,
nurses, midwives and clinical officers with experience
in delivery of both HIV and cervical cancer screening
services. The demographic characteristics of the partici-
pants are shown in Table 2. Being a qualitative study,
the sample size of 16 participants was determined by
Table 1 Characteristics of participating clinics and district health offices
Sn District Region Ownership Location Services
1 Kampala Capital city Public Urban VIA, PNC and FP
2 Kampala Capital city Public Urban VIA, Cryo, Colpo and LEEP
3 Kampala Capital city Private Urban VIA, HIV testing, ART
4 Kampala Capital city Public Urban VIA and cryotherapy
5 Kampala Capital city Private Urban HIV testing and treatment
6 Kampala Capital city Public Urban Health policies
7 Mbarara Western Public Semi-urban VIA, Cryo, Colpo and LEEP
8 Mbarara Western Public Semi-urban HIV testing and treatment
9 Mbarara Western Public Semi-urban Health policies
10 Ibanda Western Private Rural VIA and Cryotherapy
11 Ibanda Western Public Rural Health policies
12 Nakasongola Central Public Rural VIA and cryotherapy
13 Nakasongola Central Public Rural Health policies
VIA is visual inspection with 5% acetic acid solution; PNC is postnatal care; FP is family planning; LEEP is Loop Electrosurgical excision procedure; Cryo is
Cryotherapy; Colpo is Colposcopy.
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doesn’t generate any new concepts about the pheno-
menon under investigation.
Study field team and procedures
The study field team comprised of the first author (EK),
the last author (VB), four healthcare providers and four
district health officers (one from each study site). The
healthcare provider and district health officer at each
study site provided the list of names and contactTable 2 Characteristics of study participants
PID Age Sex Occupation
1 53 yrs F Nurse
2 47 yrs F Nurse
3 38 yrs F Nurse
4 25 yrs F Nurse-midwife
5 54 yrs F Midwife
6 35 yrs M Medical doctor
7 39 yrs F Gynecologist
8 41 yrs M Clinical officer
9 40 yrs F Midwife
10 38 yrs M Nurse-midwife
11 30 yrs M Nurse
12 30 yrs F Nurse
13 32 yrs F Nurse-midwife
14 46 yrs F Midwife
15 29 yrs F Nurse-midwife
16 43 yrs F Midwife
Key: PID is participant identity; F isfemale; M is male; CC is cervical cancer; yr(s) is ye
centre; RRH is Regional Referral Hospital; GH is General Hospital; ASO is AIDS Suppo
holding job positions of policy makers.addresses of all the healthcare providers and policy makers
working in HIV and CC screening clinics respectively.
The lists were then used as sampling frames to select
participants who fulfilled the eligibility criteria. All the
interviews were conducted by the first (EK) and last
authors (VB).
Sampling method for participants
The participants were selected using purposive sampling
method [23]. This sampling method allowed for selectionHealth facility address HIV work CC work
Public HC in urban area 05 yrs 12 yrs
Public HC in urban area 03 yrs 12 yrs
Private MC in urban area 08 yrs 04 yrs
Public RRH in semi-urban 03 yrs 04 yrs
Public NRH in urban area 05 yrs 05 yrs
Public HC in rural area 06 yrs 03 yrs
Public NRH in urban area 03 yrs 12 yrs
Public HC in rural area 15 yrs 03 yrs
Public HC in rural area 08 yrs 02 yrs
Private CRC in urban area 09 yrs 01 yr
Public RRH in semi-urban 05 yrs 01 yr
Public RRH in semi-urban 01 yr 01 yr
Private ASO in rural area 05 yrs 01 yr
Public NRH in urban area 03 yrs 10 yrs
Public HC in rural area 05 yrs 03 yrs
Private GH in rural area 12 yrs 04 yrs
ar(s); NRH is National Referral Hospital, HC is Health centre; MC is Medical
rt Organization; CRC is Clinical Research Centre; participants 6–8 and 14 were
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and CC screening services.Participants’ recruitment procedure
The researcher and the team visited each selected study
site to develop a list of eligible participants for each
study site. The researcher informally asked the head of
the cervical cancer clinic in each study site regarding the
HIV and CC screening work experiences of each of the
potential participant in their department. Policy makers
and healthcare providers with at least 6 months of work
experience in both HIV and CC screening clinics were
eligible to participate in the study. Based on this criterion, a
range of 1–2 policy makers and 2–4 healthcare providers
per study site were eligible to participate in the study. And
their work experience in HIV and CC screening clinics
ranged from 6 months to 12 years. Eligible participants with
at least 1 year of work experience in both HIV and CC
screening clinics were first selected and invited to partici-
pate in the study. The selected participants were invited to
participate in the study through telephone call. Meeting
appointments were made with participants who accepted
to participate in the study. All the 4 policy makers selected
and called by telephone accepted and gave appointments
to participate in the study. As for healthcare providers, 13
were selected and called by telephone, 12 accepted, 1
refused to participate in the study. The one who refused
was from a private medical centre in Kampala capital
city and her reason for refusal was lack of time to take
the interviews within the data collection period.Data collection method
Data were collected between February 2012 and February
2013. Individual interviews (IDIs) were used to collect the
data. Individual interviews was a data collection method
of choice for addressing the research question of this
study (i.e. perceptions of HCPs and PMs regarding HIV
and CC screening integration) because it has greater
potential of allowing participants to freely share sensitive
personal opinions such as beliefs, attitudes and prejudices
which are more likely to be withheld in focus groups. The
interviews were conducted by the first and last authors in
English language because being healthcare providers and
policy makers, all the participants were fluent in English
language. All the IDIs were conducted in a quiet environ-
ment outside the participant’s workplace to avoid disrup-
tion from patients and other visitors to their workplaces.
All the interviews were recorded using an audio-recording
device. A separate sheet of paper (one for each interview)
was used to record the socio-demographic data of each
participant. Participants’ names were not recorded or writ-
ten anywhere to ensure confidentiality. All the interviews
lasted for utmost 90 minutes.Interview guide
The instrument used for data collection was a semi-
structured interview guide. The interview guide was
specifically developed for the study and had items aimed
at eliciting participants’ feelings, opinions or views about
integrated delivery of HIV and CC screening services to
women in a single visit approach. The items in the
interview guide were constructed based on theory of
change and phrased in such a way to allow participants
to examine and share their perceptions of the four
quality control criteria of theory of change namely
plausibility, feasibility, testability and appropriate scope
[24]. And some of the key questions in the interview
guide include what were the participants impressions of
HIV and CC screening services integration in single visit
approach, what could be the advantages and disadvantages
of integration to the women, men, healthcare providers,
health system and funders of healthcare programs such as
government, would integration be feasible, acceptable and
appropriate in public and private health systems in low
income country such as Uganda.Data analysis
Data (in audio-recording device) were first transcribed
verbatim and then analyzed using content analysis
method [25]. The content analysis method allowed for
exploration and synthesis of codes, themes and cat-
egories. Figure 1 shows the code list together with the
corresponding themes and categories that were developed
for the entire data.Rigors of the research
Rigors of this qualitative study was ensured by paying
attention to the credibility, trustworthiness and trans-
ferability of the research [25]. The researcher’s prolonged
engagement with the data both during the collection and
analysis phases ensured credibility of the data. To ensure
trustworthiness of the study, several categories of partici-
pants also known as triangulation of data sources and also
two researchers participated in data collection and analysis
also known as triangulation of researchers [23]. Further-
more, to ensure transferability of the study, the setting
and context of the study were explicitly described in the
study sites section [25].Ethical considerations
Ethical approval for the study was obtained from Institu-
tional Review Board (IRB) of School of Biomedical Sciences
Makerere University College of Health Sciences in Uganda
and also from the Uganda National Council for Science
and Technology. Informed consents were obtained from
each participant before data collection.
Figure 1 Showing themes and subthemes.
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This manuscript is adherent to the RATS guidelines for
reporting qualitative studies which stands for relevance
of the study question (R), appropriateness of the qualitative
method (A), transparency of procedures (T), soundness of
the interpretive approach (S) [26]. This is to ensure compli-
ance with internationally acceptable standards for reporting
qualitative studies.Results
From the data analysis, three themes emerged about
integration of HIV and CC screening services. These were
appreciating benefits, worrying about the limited health
system capacity and potential consequences of integration
and feeling optimistic about integration under improved
health system conditions.Appreciating benefits of integration
All the participants viewed the integrated approach to
delivery of HIV and CC screening services will provide
benefits. The benefits mentioned were categorized as
multiple benefits to the women, economic benefits to
men, a few benefits to HCP and economic benefits to
the health system as a whole.
Multiple benefits to the women
All the participants felt that an integrated approach to
delivery of HIV and CC screening services would provide
the women with the opportunity to receive more health
services including information in a single visit to the
health facility. The participants explained that through
integration, HCP will inform and offer women the chance
to receive all the available health services whenever they
come to the integrated clinic. One participant said,
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CC screening especially in rural areas, people don’t
know anything about it but they know things about
HIV and they come for HIV testing. So if they come for
HIV testing, it’s an opportunity to tell them that you
also need to screen for CC and vice versa” – (HCP 6).
Almost all the participants thought that integration
will increase access to CC screening services among the
HIV positive women, who are the rightful target for the
service because of their increased risk of developing CC
compared to the HIV negative women. The participants
thought this is possible because the HIV positive women
are frequent visitors to the health facility for HIV ser-
vices particularly antiretroviral (ARV) drugs refills and
so chances are high that they would use one of those
visits to seek CC screening services, if integrated within
the HIV care program. One participant said,
“You are going to capture a very good number of
women especially the HIV positive women who are
usually told to return regularly to the health facility
for reviews and ARV drugs refills. Clients are going to
be very many than when you specialize” – (HCP 1).
Almost all the participants thought that integration
will prevent HIV positive women on ARV drugs dying
from CC instead. One participant explained this by say-
ing that if the CC screening aspect is ignored for the
HIV positive women, it can instead turn out to be the
cause of death of HIV/AIDS patients even though they
were put on ARV drugs, because the CC risk, disease
progression and severity is higher in the HIV-positive
population compared to the HIV-negative population.
Another participant said,
“Actually, every HIV care facility should screen women
for CC because actually women may die from CC
instead of the HIV they are treating” – (HCP 6).
Almost all the participants thought that integration
will reduce on the frequency of visits women make to
health facilities for health services. The participants
thought this to be an economic benefit to the women
because it will enable them to save on travel time and
cost to health facilities for health services. One partici-
pant said,
“…. It will be money saving and time saving, so the
people who live far away from the health facility will
be the one who will benefit most” – (HCP 12).
One participant thought that integration will help to
reduce on the worry women often get when they arereferred from CC clinic to go elsewhere for HIV testing
services.
Almost all the participants thought that integration
will facilitate early detection and treatment of other dis-
eases especially gynecological diseases that the women
may not even be aware of. The participants viewed this
as a benefit to the women because through integration
they will receive a holistic treatment of their disease
conditions. One participant said,
“From experience we have treated so many sexually
transmitted infections that we used not to identify
before integrating CC and HIV screening” – (HCP 3).
Some participants thought that integration would enable
HCP to detect and treat CC lesions at an early stage
and save many women especially the HIV positive
women from getting to the late stages of the disease.
One participant said,
“I do like the idea of integration so much because the
period the HPV infection takes to progress to invasive
cervical cancer is shorter in HIV clients so if it’s
integrated it would save many people from getting to
the last stages of the CC disease” – (HCP 4).
Many participants thought that integration will help to
minimize loss to follow up of women from CC screening
program. One participant from a private health facility
with experience of integration explained that this can
happen if HCP working in the integrated clinic try as
much as possible to match the follow up dates for CC
with that of ARV drugs refill so that when the woman
returns to the health facility for CC review she can also
get ARV drugs refill. Another participant said,
“I think integration will be a good idea. The client will
not miss either of their appointments” – (HCP 4).
All the participants from CC clinics thought that inte-
gration would enable HCP to give proper or correct fol-
low up schedule for the HIV positive women who turn
out to be positive for cervical pre-cancerous lesions e.g.
setting up an aggressive follow up schedule usually after
every 1 year instead of after every 3 years for the HIV
negative women. One participant said,
“I think integration will be a good opportunity because …,
reason being the way we manage those who are HIV
positive with cervical lesions, their follow up has to be
aggressive. While for her (the HIV positive woman) we
tell her you need to come back after 1 year and yet we
would have told her to come back after 3 years if she
were HIV negative” – HCP 7.
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screening integration will increase the availability of CC
screening sites for women. The participants explained that
HIV testing sites are very many, almost in all health facil-
ities countrywide and if each of them integrates CC screen-
ing services then the number of CC screening sites will also
increase countrywide, making the CC screening services
widely available to women. One participant explained,
“Integrating HIV and CC screening will be a very good
check, it will at least increase community awareness
about the CC screening and its availability definitely
will also increase” – (HCP 16)
Knowledge and skills benefits to the HCP
A few participants thought that integration will enable
HCP to acquire more knowledge and skills in delivery of
both HIV and CC screening services. One participant said,
“…. maybe acquiring the skills of how to screen for HIV
which most of them have been trained in but currently
in our CC clinic we are not doing it” – HCP 7.
Similarly, a few participants thought that integration
will ease work for HCP as it will enable them to make
correct diagnosis and proper treatment for the women,
which will in the long run save the HCP time for seeing
the same woman again for the same complains. One
participant said,
“I think even us health workers, it ease our work
because you will get rid of many of the diseases you
have to treat. You don’t only provide ARV drugs for
HIV treatment but you also provide these other drugs
anti-fungal, antibiotics. Many times they (women) come
to the health facility thinking that it’s maybe STIs,
urinary tract infections (UTIs) or pelvic inflammatory
diseases (PID). You think you are treating a PID when
it’s actually CC. So I think it helps us to diagnose a
client well before giving the treatment” – (HCP 4).
More than economic benefits to men
It further emerged that participants of this study viewed
integration will also provide some benefits to men.
Almost all the participants thought that integration
will also enable men save both on transportation time
and cost of their female partners to the health facility for
health services. A few of the participants shared their
observation that integration has in fact encouraged male
involvement in reproductive health of women especially
their female partners. One participant said,
“The husbands will accept it because of the
transportation issue. They will actually like the ideathat they only have to pay one transport cost for both
screening so it will be both time and cost saving to
them, instead of paying this week for one test and then
next week go for the other tests ” – (HCP 12).
Another benefit of integration to men expressed by a
few of the participants of this study was the possibility
that men who accompany the women to the health facility
would themselves utilize some of the services such as
listening to health education talks, HIV counseling and
testing from the integrated clinic.Economic benefit to the health system
Most of the participants thought that integration will
provide economic benefits to the health system as a
whole. Almost all of them mentioned that integration
will reduce the health expenditure in that it will be less
expensive for the health system to deliver services in an
integrated approach. One participant explained,
“It also reduces on the expenditure of the health system
because instead of health workers going and making an
outreach for HIV and making another outreach for CC
screening, you have an opportunity to do both of them
on the same client on the same day which is less
expensive for the health system” – (HCP 6).Worrying about limited health system capacity and
potential consequences of integration
Almost all the participants felt worried that HIV testing
may instead become a barrier to uptake of CC screening
services especially among women who do not want to
take HIV test because of fears of HIV stigma. One
participant said,
“The disadvantage of integration is that people
associating CC screening with HIV testing. People may
fear to come for the CC screening knowing that if you
go to the screening, they will also test for HIV. There
are some people who may fear” – (HCP 6).
Similarly, all the participants felt worried that integration
will increase the workload for HCP which will subsequently
affect their efficiency and productivity. One participant
said,
“With integration, the HCP will have a lot to do. They
will have the double workload of dealing with both
HIV testing and CC at the same time” – (HCP 12).
Furthermore, a few of the participants felt worried that
integration would make HCP to screen very few women
per day. One participant said,
Kumakech et al. BMC Public Health 2014, 14:810 Page 8 of 12
http://www.biomedcentral.com/1471-2458/14/810“But I think with integration, we can only serve 5
clients in a day, but the others who came but weren’t
served will be offended” – (HCP 12).
Feeling compassion for the women
A few of the participants felt compassion for the women
will turn out to be double positive i.e. positive for both
HIV and CC lesions because they thought it would make
them more miserable. One participant said,
“Sometimes they (women) don’t want to also know
their HIV status because they say why should I know
now, it will make me more miserable if also found
positive” – (HCP 7).
Similarly, almost all the participants felt compassion
for the women whose waiting time at the health facility
would be prolonged due to the integrated approach be-
cause they thought it would offend them. One partici-
pant said,
“The only disadvantage to the woman maybe is the
longer waiting time because before we screen her we
are going to have a counseling session, then she will be
screened for HIV, then she will wait for the results of
the HIV test and then she will again be screened for
CC, maybe more time at the Clinic that’s the only
disadvantage to the women” – (HCP 7).
More so, a few of the participants also felt compassion
for the women who will be unable to comprehend both
concepts of HIV and CC screening services that will be
presented to them in an integrated format.
Feeling optimistic about integration under improved
health system conditions
There were positive feelings among almost all the partic-
ipants that integration would be feasible under improved
conditions. And conditions were categorized as improv-
ing resources and minimized waiting time for women at
the health facility.
Improved resources
Almost all the participants emphasized the importance
of recruiting more HCP to do the extra work that will
be created by the integration. One participant said,
“Integration is possible only if extra healthcare staff is
provided” – (HCP 12).
Also many participants expressed their view that for
integration to be effectively implemented every supplies
required including drugs have to be made available. One
participant said,“HIV clients have many gynecological diseases such as
cervicitis, bleeding all the time, cervical warts, you
have to be equipped with drugs” – (HCP 2).
A few participants thought that integration can work if
the existing facilities can be adapted to create space for
counseling, CC screening, treatment and then the HIV
testing. One participant said,
“Where they are having more place everything should
run in the same place, you can put there cancer
screening, HIV screening, the treatment, everything,
you proceed…” – (HCP 5).
More so, all the participants expressed their view that
HCP should be trained in both HIV and CC screening
to acquire the necessary skills to provide the services
in an integrated manner. One participant shared how
being trained in both HIV and CC screening helps in
integration,
“If they come to the CC clinic, us who do the cancer
screening are also trained in Antiretroviral therapy
(ART) so you do the CC screening and also write them
the ARV drugs so they go because one of the things they
did was to take us for training in the ART, so that saved
a lot on their waiting time at the facility” – (HCP 4).
Minimized waiting time for women
Almost all the participants thought that integration
would work if effective strategies are put in place to
minimize women’s waiting time at the health facility.
Most of the participants felt that in order to address the
issue of long waiting time for women at the integrated
clinic, a team of HCP should be put in place to perform
the different tasks in the integrated clinic. One participant
said,
“it shouldn’t be the same HCP to provide both the HIV
and CC screening reasons being, you need to put on
gloves, touching genitals of the woman and for HIV
testing you are touching blood, you need to be different
people so that you are fast” – (HCP 2).
A few participants expressed their view that there is
need for the integrated clinic staffs to collaborate with the
laboratory unit personnel who run the HIV tests so as to
speed up the HIV testing procedure. One participant said,
“We have to collaborate with the laboratory people, for
you will take the blood and finish CC screening in 2–3
minutes but the HIV results will delay in the
laboratory, at least the laboratory personnel should
take 20–30 minutes” – (HCP 1).
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the strategy should be to book a few women per day for
the integrated screening. One participant said,
“But we try to handle that (delay of clients in queue)
by booking a few clients per day. We can have like 10
women to screen on one day to reduce on the waiting
time. I personally have not found any challenge with it
(integration). First of all, I book specific number of
clients I will see that day. If I have 10 people, I work
on that for my day” – (HCP 4).
Some participants expressed their view that all the
HCP with the required expertise should be put to work
together whenever possible in the same room. One
participant said,
“We had the issue of long waiting time initially, but we
solved it by integrating everything in the same room.
When someone comes, there is a doctor to see them;
there is another HCP to screen them for CC at the
same point, not allowing them to go to stand in
several queues at different service points. By the time
the client leaves the clinic, they just go to the
pharmacy to collect their prescribed drugs” – (HCP 3).
Furthermore, almost all the participants thought that a
non-mandatory approach to integration should be adopted
in order to allay fears of long waiting time and not to chase
away women who may not be ready to receive both tests in
a single visit and also to dissociate CC screening from HIV
testing. One participant said,
“….. It’s very important that we don’t make it
compulsory. We should openly tell them that they are
free, they can decide to take both or one
test……………… I think the important thing is to make
it optional, give them the information but leave it
optional so that people don’t connect HIV testing to
CC screening”– (PM 4).
Discussion
One of the key findings of this study was the view by
HCP as well as PM that integration of HIV and CC
screening would provide benefits to all the concerned
stakeholders. This included benefits to the women, to
the men, to healthcare providers and to the health sys-
tem. More so, HIV and CC integration was viewed to
provide more benefits to the women than to any of the
other stakeholders. The manifold benefits of an inte-
grated approach to HIV and CC screening expressed by
participants of this study concurs with those observed
by Mwanahamuntu et al., [17] in Zambia. In both of
these studies, the benefits mentioned included resourceand infrastructure sharing, availability of a wider range of
women’s health services for HIV infected/at-risk women,
and opportunities for referral between the clinic systems
and maximization of participation in both programs.
These similarities of study findings could be an indication
that stakeholders across Africa share a common view
about the benefits of an integrated approach to HIV and
CC screening.
Notably, there were many other benefits of integration
that were expressed by participants of this study which
were not expressed in previous studies. This includes
the view that HIV and CC screening integration would
reduce on the frequency of visits women would make to
health facilities for healthcare services, travel time and
cost saving to the women and their male partners, mini-
mized loss to follow up of women scheduled for HIV
and CC treatment, and correct or proper management
of HIV positive women with cervical precancerous lesions.
These additional benefits of HIV and CC screening
integration if incorporated into community education
programs could provide motivations for women to seek
HIV and CC screening.
The view by the participants of this study that HIV
and CC screening integration would provide opportunity
for women to receive early detection and treatment for
other gynecological diseases such as STIs concurs with
Were et al., [18] findings in Kenya regarding CC screening
integration into MCH and FP clinics. The benefits of
detecting other gynecological diseases in the woman is
irrespectively derived from the visual methods as a CC
screening method because the procedure allows the
HCP to visualize the genitalia of the women for signs of
gynecological diseases. We think this benefit of detection
of other gynecological diseases is less likely to be realized
if other CC screening methods rather than the visual
methods were used in the integration.
Notably, this study revealed that despite the general
consensus among almost all categories of the participants
that HIV screening programs in Uganda are more wide-
spread and have better coverage than CC screening, there
were conflicting views on whether integration would be of
benefit to women who do not attend HIV centres because
of the fear of HIV/AIDS stigma or they would similarly
become reluctant to attend CC clinics where HIV testing
is also offered. Future research should address this ques-
tion as previous HIV/AIDS stigma studies haven’t really
examined whether HIV/AIDS stigma diminishes with the
type of clinic.
The participants of this study thought that integration
of HIV and CC screening would also provide economic
benefits to men as well as encourage reproductive health
seeking behaviors among them. This finding is logical
because in some Ugandan cultures, men are responsible
for the medical bills of their female partners and often
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attend the health talks about HIV or CC provided by the
HCP. After attending the health talks, it is possible that
some men can decide to seek for health services for them-
selves, e.g. HIV screening and therefore attain more than
economic benefits from the integration.
Another finding of this study was the perception by
the participants that HIV and CC screening integration
would provide HCP with the opportunity to acquire
more knowledge and skills in both HIV and CC screen-
ing services. It is logical that HCP will acquire more
experiential knowledge and skills as they practice from the
integrated clinic. The unanswered question is whether
this perceived benefit (acquiring more knowledge and
skills) outweighs the perceived challenge of integration
(e.g. increased workload) to act as a cue to the action of
integration among HCP.
More so, the view of the participants of this study that
integration would reduce on the health expenditure con-
curs with that of Mwanahamuntu et al., [17] in Zambia
that integration allows for sharing of resources and
infrastructure between HIV and CC programs, which in
a way reduces the health expenditure. This particular
finding about the potential of integration to leverage
resource sharing between HIV and CC programs could
be incorporated into advocacy materials targeting Ministry
of Health officials, planners and policy makers.
Furthermore, consistent with previous studies was this
study finding that there were worries among almost all
the participants that HIV stigma would affect uptake
of CC screening services from an integrated clinic. The
same worry was expressed about HIV and CC screening
integration in Zambia by Mwanahamuntu et al., [17].
This implies that across African countries, HIV stigma is
still a reality and continues to deter some people from
accessing HIV services despite the huge investment in
HIV/AIDS programs. And therefore, strategies for
dissociating HIV testing from CC screening such as
opt-out options should be in-built in all informational
or educational materials about integrated HIV and CC
screening services. Efforts should also be made to reduce
HIV/AIDS-related stigma.
Also consistent with previous studies was this study
finding that almost all the participants expressed their
worry that HIV and CC screening integration would
increase workload for HCP. Increased workload was
thought to lead to negative consequences such as
screening fewer women per day, prolonged waiting time
for women at the health facility and failure to screen all
and hence disappointment of some women who have
come to the clinic for screening. The same worry was
expressed in another African country, Mozambique,
where a pilot CC screening was implemented among
women attending HIV care program [27]. The similarityin the findings from the two studies can be explained by
the shortage of HCP which is a problem in both countries
and many other African countries.
The study finding that almost all the participants felt
optimistic about the feasibility of integrating HIV and
CC screening under improved conditions of the health
system is also consistent with the previous study in
Mozambique [27]. The study in Mozambique recom-
mended for improvements in the health infrastructure to
create room for CC screening integration into HIV care
facilities.
Although the use of HPV DNA testing on self-collected
vaginal samples as one of the CC screening algorithm
options for integration with HIV testing didn’t emerge
from the study but because of its potential in addressing
some of the perceived challenges of integration observed
in this study such as delay of women at the integrated
clinic and increased workload for HCP makes it worth
discussing. With HPV DNA testing on self-collected vagi-
nal samples as the CC screening algorithm of choice,
women could do self-sampling from home or laboratory
and pass via the laboratory for HPV DNA and HIV testing
first. And those with positive test results could proceed to
the integrated clinic for pelvic examination using visual
inspection with acetic acid (VIA) and treatment. The
HPV DNA testing with self-sampling for CC screening
algorithm has the advantages of increasing CC screening
coverage among women, minimizing the delay of women
at the health facility and evenly dividing the workload
created by integration among laboratory and clinic
HCP. The disadvantage would be that women with HPV
DNA negative test results will miss pelvic examination
with visual methods plus its other benefits such as detec-
tion and treatment of unsuspected STIs by the HCP at the
integrated clinic.
Study limitations
Just like all studies, this study is not without limitations.
The qualitative nature of the study couldn’t allow large
sample size and consequently the study findings are not
meant to be generalizable. More so, the use of interview
method of data collection for this study carries the risk
of response bias – that is the tendency of some respon-
dents to distort their responses and the most pervasive
being the tendency to present a favorable image of the
phenomenon under investigation [28]. Response bias
was minimized in this study by the interviewer being
aware of the many ways the results can inadvertently be
biased by the interview as a data collection method and
bracketing them during the interview. Worse still, the
use of qualitative content analysis for data analysis
suffers from the risk of subjectivity [28]. This risk of
subjectivity was minimized by two of the investigators
first analyzing the data independently and then jointly
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themes or categories. Nevertheless, in view of the above
limitations of interviews and content analysis methods
employed in this study, the results and conclusions should
be interpreted and used within the context of Uganda or
similar healthcare system in low resource settings unless
otherwise.Conclusions
Integration of HIV and CC screening can offer manifold
benefits to all stakeholders in the health system, more
so to the women. However, its feasibility in developing
countries such as Uganda is likely to be hampered
by weak and inefficient health system characterized by
limited infrastructure, insufficient drugs and clinical
supplies, inadequate and poorly motivated HCP. HIV
stigma continues to linger as a stumbling block that can
potentially affect access to services from an integrated
HIV and CC screening program.
When considering integration of HIV and CC screening,
it is important for policy makers and clinicians to take into
account the existing weaknesses and limitations in the
health systems. This could be issues to do with availability
and skills set of HCP, space (infrastructure), drugs and
clinical supplies, linkages to other departments such as
laboratories and ART clinic and speed or turnaround time
of service delivery. Careful consideration of motivation
mechanisms for HCP is equally important. The above
areas have to be improved before considering integration
of HIV and CC screening.
On the side of the clients, it is important to ensure
that effective mechanisms and procedures are in place
for booking clinic appointments, minimizing waiting time,
pre and post-test counseling women and for addressing
HIV stigma both at clinic and community settings. Policy
makers and HCP should weigh the cost of fixing the
existing weaknesses and limitations in the health system
against the benefits of integration of HIV and CC screening
as a pre-requisite to integration.
The choice of CC screening algorithm for integration
with HIV screening is another critical area for Clinicians
to consider. An algorithm that uses HPV testing with
self-sampling for triage is most likely going to be faster
and will not only reduce on women’s waiting time at the
integrated clinic but also reduce on the number of
women proceeding to the next stage of CC screening
using visual methods or cytology.
Non-mandatory approach to integration with opt-out
options for women could be one way of increasing the
participation and utilization of the HIV and CC integrated
screening services among women who are reluctant
to attend clinics where HIV testing is practiced because
of fears of HIV stigma. Messages on the opt-out optionscould be part and parcel of community education out-
reaches for HIV and CC screening.
And lastly, future research should explore perceptions
of HIV and CC screening service integration among
community members particularly women, men and
community health workers. Such studies will hopefully
address questions regarding community acceptability of
the HIV and CC care integration in low income country
such as Uganda.
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